About this trial
Coeliac disease (CD) is an immune-mediated enteropathy leading to small intestinal mucosal atrophy. Diagnosis relies on serology and duodenal biopsies, but it can be complicated by patchy lesions and differential diagnosis with Non-Celiac Enteropathies (NCEs). This multicenter observational study aims to develop and validate an Artificial Intelligence (AI) system to detect and characterize small bowel mucosal atrophy and other pathological findings using endoscopic imaging. The study involves a retrospective phase for training the AI model and a prospective phase to validate its diagnostic accuracy compared to standard human assessment.
Eligibility criteria
Qualifiers
Adult patients (age ≥18 years).
Patients undergoing endoscopic investigation of the small bowel (endoscopy or capsule endoscopy)
Disqualifiers
Inability to provide informed consent.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Istituti Clinici Scientifici Maugeri SpA
Lead sponsor
Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Collaborator
Valduce Hospital
Collaborator
Azienda Ospedale Università Padova, Padova
Collaborator
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Collaborator
ASST Cremona, Cremona
Collaborator
Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino
Collaborator
Fondazione Poliambulanza Istituto Ospedaliero, Brescia
Collaborator
Asst Degli Spedali Civili Di Brescia
Collaborator
IRCCS Policlinico San Donato, Milano
Collaborator
Azienda Socio-Sanitaria Territoriale (ASST) di Pavia
Collaborator
Azienda Unità Sanitaria Locale della Romagna
Collaborator
ASST Lecco, Lecco
Collaborator
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policinico, Milano
Collaborator
Academic Unit of Gastroenterology, Sheffield Teaching Hospitals, Sheffield, UK
Collaborator